XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)    
Revenues $ 136,958 $ 100,606
Transaction costs ($320 interest expense and fees associated with related party transaction during the three months ended March 31, 2022, refer to Notes 6 and 14 for further information) 25,575 20,155
Other operating expenses 34,759 26,614
Research and development expenses 25,915 16,653
Sales and marketing expenses 34,469 23,139
General and administrative expenses 18,128 10,517
Depreciation and amortization 4,455 4,677
Total operating expenses 143,301 101,755
Operating loss (6,343) (1,149)
Financial income (expense):    
Gain from change in fair value of Warrants 31,196  
Other financial expense, net (2,695) (622)
Financial income (expense), net 28,501 (622)
Income (loss) before taxes on income and share of gain (loss) of associated company 22,158 (1,771)
Taxes on income 1,967 1,731
Share in gain (loss) of associated company 20 (6)
Net income (loss) $ 20,211 $ (3,508)
Per share data    
Net income (loss) per share attributable to common stockholders - Basic earnings (loss) per share $ 0.06 $ (0.16)
Diluted earnings (loss) per share $ 0.06 $ (0.16)
Weighted average common shares outstanding - Basic 342,324,722 54,868,825
Weighted average common shares outstanding - Diluted 365,992,174 54,868,825